Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Traveling for the glycosphingolipid path.

S Hakomori1

  • 1Division of Biomembrane Research, Pacific Northwest Research Institute, Seattle, WA 98122, USA. hakomori@u.washington.edu

Glycoconjugate Journal
|June 26, 2001
PubMed
Summary

This study characterizes glycosphingolipids (GSLs) and their changes during development and cancer, identifying novel tumor-associated antigens and their roles in cell adhesion and signaling. Findings support GSLs as targets for cancer diagnostics, therapeutics, and anti-adhesion strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of b16 melanoma metastasis by administration of g(m3)- or gg3- liposomes - blocking adhesion of melanoma-cells to endothelial-cells (antiadhesion therapy) via inhibition of g(m3)-gg3cer or g(m3)-laccer interaction.

International journal of oncology·2011
Same author

P-selectin-dependent adhesion of human cancer-cells - requirement for coexpression of a psgl-1-like core protein and the glycosylation process for sialosyl-le(x) or sialosyl-le(a).

International journal of oncology·2011
Same author

Cooperative inhibitory effect of n,n,n-trimethylsphingosine and sphingosine-1-phosphate, co-incorporated in liposomes, on b16 melanoma cell metastasis - cell-membrane signaling as a target in cancer-therapy .4.

International journal of oncology·2011
Same author

Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs.

International journal of oncology·2011
Same author

Inhibition of MAP kinase by sphingosine and its methylated derivative, N,N-dimethylsphingosine.

International journal of oncology·2011
Same author

Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.

Advances in experimental medicine and biology·2003

Area of Science:

  • Glycobiology and Cancer Research

Background:

  • Glycosphingolipids (GSLs) are crucial in cellular processes, with alterations observed during development and oncogenesis.
  • Initial characterization focused on lacto-series and globo-series GSLs, including histo-blood group antigens.

Observation:

  • Novel GSLs, such as sialyl-Le(x) and dimeric structures, were identified as tumor-associated antigens.
  • GSL changes correlate with ontogenic development, differentiation, and tumor progression.
  • GSLs play roles in cell adhesion, exemplified by embryo compaction, and modulate signal transduction via growth factor receptors.

Findings:

  • Established GSL structures and their dynamic changes during development and cancer.
  • Demonstrated GSL clusters forming 'glycosignaling domains' that mediate cell adhesion and signal transduction.

Related Experiment Videos

  • Identified specific GSLs and glycoepitopes for potential medical applications.
  • Implications:

    • GSLs are key regulators of cell adhesion and signaling, influencing development and disease.
    • Tumor-associated GSLs offer targets for cancer diagnostics, vaccine development, and anti-adhesion therapies.
    • Future research on GSL mimetics could lead to novel treatments for metastasis, infection, and inflammation.